How should a skin tag in an infant younger than four months be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Skin Tags in a 4-Month-Old Infant

A skin tag in a 4-month-old infant should be carefully examined to rule out preauricular location and associated anomalies, with most simple skin tags observed without intervention at this age, while preauricular tags warrant hearing screening and evaluation for urinary/cardiac malformations.

Initial Evaluation

The first critical step is determining the location and characteristics of the skin tag:

Preauricular Tags (Near the Ear)

If the skin tag is located in the preauricular region, this requires a different approach than tags elsewhere on the body:

  • Hearing assessment is mandatory - Preauricular skin tags are associated with a significantly increased risk of permanent hearing impairment (8 per 1000 vs 1.5 per 1000 in unaffected infants), with an adjusted odds ratio of 4.9 1
  • Screen for associated malformations - Perform renal ultrasound and cardiac ultrasound, as preauricular tags carry increased risk for congenital urinary tract and heart malformations 2
  • Careful clinical examination to distinguish between true skin tags (without pilosebaceous units, with thin soft pedicle) versus accessory tragus or hair follicle nevi, as misdiagnosis can lead to complications like chondritis 3

Non-Preauricular Tags

For skin tags located elsewhere (neck, trunk, axilla, groin):

  • Observation is appropriate at 4 months of age - These are benign lesions that primarily represent aesthetic concerns
  • Examine for any signs of trauma, bleeding, or infection
  • Document size, location, and characteristics

Management Approach

Conservative Management (Preferred at 4 Months)

Watchful waiting is the recommended approach for simple skin tags in infants:

  • Skin tags are benign and pose minimal risk
  • Many can be managed conservatively without intervention in infancy
  • Treatment can be deferred until the child is older if purely cosmetic

When to Consider Intervention

Intervention may be considered if:

  • The tag is subject to repeated trauma with bleeding
  • Signs of infection develop
  • Significant parental concern after counseling

Treatment Options (If Needed)

For preauricular skin tags specifically in newborns, Ligaclip application can be performed safely in carefully selected cases (thin, soft pedicle without pilosebaceous unit), with the tag falling off in 7-10 days 3. However, at 4 months of age, this window has passed.

Important Caveats

  • Never use over-the-counter mole/skin tag removers - These unapproved products containing concentrated salicylic acid, Sanguinaria canadensis, or other caustic agents cause serious burns, ulceration, permanent scarring, and disfigurement 4
  • Distinguish skin tags from congenital melanocytic nevi, which require different management
  • If there is any uncertainty about the diagnosis, referral to pediatric dermatology is appropriate

Follow-Up

  • For preauricular tags: Ensure hearing screening is completed and imaging studies are performed 1, 2
  • For other locations: Routine monitoring during well-child visits
  • Educate parents about signs requiring urgent evaluation (rapid growth, bleeding, pain, ulceration)

References

Research

Ligaclip for Preauricular Skin Tags in the Newborn.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2021

Research

Serious Skin Injuries Following Exposure to Unapproved Mole and Skin Tag Removers.

The Journal of clinical and aesthetic dermatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.